Supply of Ringer’s Lactated Injection (500 mL)

The contract calls for the manufacture and delivery of sterile Ringer’s Lactated Injection, USP, in 500 mL units, packaged in cases of 24 units per pallet, to meet stringent FDA current Good Manufacturing Practices, defined shelf-life requirements, and specific military packaging and labeling standards. The product must comply with all regulatory and logistical specifications mandated by the Department of Defense, ensuring suitability for use in military medical operations. Delivery is to be performed to Fort Bliss, Texas, with the ZIP code 79918-2527 designated as the place of performance. This subcontract, posted on July 26, 2026, with a response deadline of August 3, 2026, falls under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The contract is administered by the Medical Supply Chain Pharm FSA, a component of the Department of Defense, and is accessible via the DIBBS platform. All bidders must adhere to the technical, quality, and packaging criteria outlined to ensure full compliance with military medical supply protocols, and failure to meet these standards may result in rejection of the proposal.